Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Feedback Appoints Ex-Chair Of Silence Therapeutics Riddell As Chairman

1st Jun 2016 11:44

LONDON (Alliance News) - Medical imaging software company Feedback PLC on Wednesday said it has appointed Alastair Riddell as its non-executive chairman with immediate effect.

Riddell takes over from Tom Charlton, who will become deputy chairman and will step down from the board after Feedback's annual general meeting, which is expected to take place in November.

Riddell sits on the boards of three biotechnology companies at present - AzurRx Bioetherapeutics, Cristal Therapeutics and Skyline Vet Pharma - and is a former chairman of Silence Therapeutics PLC, the AIM-listed cancer drug discovery firm.

Feedback shares were untraded on Wednesday, having last traded at 1.38 pence.

By Sam Unsted; [email protected]; @SamUAtAlliance

Copyright 2016 Alliance News Limited. All Rights Reserved.


Related Shares:

SLN.LFeedback
FTSE 100 Latest
Value8,809.74
Change53.53